EP Patent

EP0596406A1 — Imidazo (1,2-a) Pyridines as bradykinin antagonists

Assigned to Fujisawa Pharmaceutical Co Ltd · Expires 1994-05-11 · 32y expired

What this patent protects

A compound of the formula : wherein R 1 is halogen, R 2 and R 3 are each hydrogen, lower alkyl, halo(lower)alkyl or acyl, R 4 is aryl having suitable substituent(s), or a heterocyclic group optionally having suitable substituent(s), Q is O or N-R 11 , in wh…

USPTO Abstract

A compound of the formula : wherein R 1 is halogen, R 2 and R 3 are each hydrogen, lower alkyl, halo(lower)alkyl or acyl, R 4 is aryl having suitable substituent(s), or a heterocyclic group optionally having suitable substituent(s), Q is O or N-R 11 , in which R 11 is hydrogen or acyl, and A is lower alkylene, and pharmaceutically acceptable salts thereof, processes for their preparation and pharmaceutical compositions comprising them as an active ingredient.

Drugs covered by this patent

Patent Metadata

Patent number
EP0596406A1
Jurisdiction
EP
Classification
—
Expires
1994-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Fujisawa Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.